Latest Breaking News On - Stefano portolano - Page 1 : comparemela.com

Azafaros Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Azafaros Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRoberto giuglianiPorto alegreDrug administrationGenetics serviceLeiden universityEuropean medicines agencyHealthcare products regulatory agencyMedical genetics serviceHospital clinicas de porto alegreLead principal investigatorDaniel almeidaStefano portolanoRare pediatric disease designationsUnited states food

Azafaros Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolledTopline data from the study, exp.

United kingdomUnited statesPorto alegreRoberto giuglianiLeiden universityEuropean medicines agencyDrug administrationHealthcare products regulatory agencyGenetics serviceAzafaro phaseMedical genetics serviceHospital clinicas de porto alegreLead principal investigatorDaniel almeidaStefano portolanoRare pediatric disease designations

Beyond Biotech podcast 35: Rare Disease Day

To mark Rare Disease Day on February 28, our guests this week are from GRO Biosciences, Azafaros, and Replay.

United statesUnited kingdomDan mandellLachlan mackinnonAdrian woolfsonUniversity of texas md anderson cancer centerEuropean medicines agencyDrug administrationLeiden universityHealthcare products regulatory agencyRare disease dayStefano portolanoCancer centerRare pediatric disease designationsUnited states foodOrphan medicinal product designation

FDA Grants Fast Track Designation to Azafaros Treatment for Lysosomal Storage Disorders

FDA Grants Fast Track Designation to Azafaros Treatment for Lysosomal Storage Disorders
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesMayo clinic in rochesterMarc pattersonDrug administrationFast trackAzafaro investigational new drugFast track designationStefano portolanoMedical geneticsMayo clinic

Azafaros Announces FDA Grant of Orphan Drug Designation for AZ-3102 in the Treatment of Niemann-Pick Disease

Second Orphan Drug Designation Supports Azafaros' Strategy to Develop AZ-3102 as a Disease Modifying Treatment in a Range of Severe Rare Inherited Metabolic Disorders Azafaros B.V. today announced

Noord hollandKostenloser wertpapierhandelEva mulderMarie theresa weickertSchroder adveqAmsterdam university medical centerDrug administrationLeiden universityTrophic communicationsDisease modifying treatmentSevere rare inherited metabolic disordersOrphan drug designationStefano portolanoChief executive officerDrug designationAmsterdam university medical